At what age can chamomile tea be safely administered to a pediatric patient? | Rounds At what age can chamomile tea be safely administered to a pediatric patient? | Rounds
Loading...

At what age can chamomile tea be safely administered to a pediatric patient?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Pediatric Chamomile Tea Administration Age

No evidence-based minimum age for chamomile tea administration exists in major public guidance. [1] Chamomile is described as likely safe when used orally in amounts commonly found in teas and other foods, with possibly safe short-term oral medicinal use in adults and children. [1] For regulated herbal “medicinal product” preparations, use is generally for adults and adolescents above 12 years of age, with only some preparations recommended for children below 12 years according to product-specific instructions. [2]

Age-Based Guidance From Public Safety Summaries

Chamomile oral intake in food/tea amounts is described as likely safe across pediatric patients, with no specified lower age cutoff. [1] Chamomile oral use for medicinal purposes is described as possibly safe for children only for short-term use, with limited safety information overall. [1] For medicinal chamomile preparations, product labeling guidance applies, because only some preparations are recommended for children below 12 years. [2]

Risk Considerations That Drive Conservative Pediatric Use

Allergic reactions are possible because chamomile can cross-react with other plants in the same botanical family. [1]

Practical Administration Approach

Chamomile tea use for a pediatric patient is best limited to amounts commonly found in teas and foods. [1] Medicinal use of chamomile preparations should follow product labeling and should be avoided when pediatric-specific instructions are absent. [2]

Situations Requiring Clinician Input

Clinician input is recommended for pediatric patients when a defined “medicinal” chamomile product is being considered rather than tea/food-level exposure. [2] Clinician input is recommended when allergy risk exists due to known or suspected plant-related allergies. [1]

When an Absolute “Safest Age” Cannot Be Determined

No guideline specifies a single starting age (for example, “age 1” or “age 2”) for safe chamomile tea administration. [1]

Sources

Related Questions